News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

By Jeffrey Guhin, Slate | 07.05.2016

“Scientism” is the belief that all we need to solve the world’s problems is, you guessed it, science. People sometimes...

By Moira Weigel, The Guardian [US] | 07.05.2016

In the febrile world of health startups, entrepreneurs are racing to quantify every possible bodily and environmental function. And so...

By David Jensen, California Stem Cell Report | 07.05.2016
The prestigious journal Nature today editorialized against easing federal regulation of stem cell treatments, a major blow to the campaign...
By Jordan G. Teicher, Slate | 07.05.2016

In 2005, Norwegian artist Anne-Karin Furunes was browsing in the library at Sweden’s Uppsala University when she happened upon a...

By Malcolm Dando, Nature World View | 07.05.2016

In Geneva next month, officials will discuss updates to the global treaty that outlaws the use of biological weapons. The...

By Sharon Begley, STAT | 07.05.2016

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at...

By Editorial Board, Nature | 07.05.2016

You may have heard that regulators in the United States are too strict when it comes to stem-cell treatments. If...

By Andrew Pollack, The New York Times | 07.04.2016

LOS ANGELES — A state ballot initiative meant to lower prescription drug prices for California faces an expected opponent: the...